Semaglutide (Wegovy)

  • Part D specialty tier in 55% of formularies (2026Q3)
  • Wegovy

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Semaglutide (Wegovy): storage and handling

Refrigerate
Yes, as the label states
Label statement
Single-dose Pen or Single-dose Syringe Storage Store the WEGOVY prefilled single-dose pen or single-dose syringe in the refrigerator from 2°C to 8°C (36°F to 46°F).
Freezing
Do not freeze
Label statement
Do not freeze WEGOVY and do not use if it has been frozen.
Room temperature
up to 28 days at or below 30°C (86°F)
Label statement
Throw away the pen if WEGOVY has been frozen, has been exposed to light or temperatures above 86°F (30°C), or has been out of the refrigerator for 28 days or longer.
Back into the refrigerator
Not addressed
Light
Protect from light
Label statement
Keep WEGOVY in the original carton to protect it from light. .
Shaking
Not addressed

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

Within the label's stated room-temperature allowance (up to 28 days at up to 30°C (86°F)). Follow the label's instructions for what to do next.

Entered: 1 day at up to 77°F (25°C).

Throw away the pen if WEGOVY has been frozen, has been exposed to light or temperatures above 86°F (30°C), or has been out of the refrigerator for 28 days or longer.
Discard the WEGOVY pen or syringe after use.
Always remove and safely discard the needle after each injection.

If anything else happened to the product, or you are unsure, Contact the manufacturer at 1-833-934-6891 (the number printed on the label) about this product.

Where the label prints this number
at 1-833-934-6891.
All storage statements on the label (20)
  • Do not store WEGOVY in the freezer or directly adjacent to the refrigerator cooling element. .
  • Do not freeze WEGOVY and do not use if it has been frozen.
  • Single-dose Pen or Single-dose Syringe Storage Store the WEGOVY prefilled single-dose pen or single-dose syringe in the refrigerator from 2°C to 8°C (36°F to 46°F).
  • If needed, prior to the pen or syringe cap removal, the pen can be kept from 8°C to 30°C (46°F to 86°F) up to 28 days.
  • WEGOVY injection must be kept in the original carton until time of administration.
  • Discard the WEGOVY pen or syringe after use.
  • Single-patient-use Pen (WEGOVY FlexTouch) Storage Prior to first use, store WEGOVY FlexTouch single-patient-use pen in a refrigerator between 2°C to 8°C (36°F to 46°F).
  • After first use, WEGOVY FlexTouch single-patient-use pen can be stored for 56 days between 15°C to 30°C (59°F to 86°F) or in a refrigerator 2°C to 8°C (36°F to 46°F).
  • WEGOVY FlexTouch single-patient-use pen should be protected from excessive heat and light.
  • Always remove and safely discard the needle after each injection.
  • Store the WEGOVY FlexTouch single-patient-use pen without an injection needle attached.
  • Store and dispense WEGOVY tablets in the original bottle.
  • Store WEGOVY tablet in the original bottle until use to protect tablets from moisture.
  • Store WEGOVY tablets in a dry place away from moisture.
  • How do I store WEGOVY? .
  • Store the WEGOVY pen in the refrigerator between 36°F to 46°F (2°C to 8°C). .
  • If needed, before removing the pen cap, WEGOVY can be stored from 46°F to 86°F (8°C to 30°C) in the original carton for up to 28 days. .
  • Keep WEGOVY in the original carton to protect it from light. .
  • Do not freeze . .
  • Throw away the pen if WEGOVY has been frozen, has been exposed to light or temperatures above 86°F (30°C), or has been out of the refrigerator for 28 days or longer.

FDA label version 19, effective June 18, 2026. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

3%of plans list it
100%of those: prior authorization
0%step therapy
29%quantity limit
13%specialty tier

5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan

Patient assistance

No manufacturer program page is listed for this drug yet.

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.